Cell Therapy

News

AstraZeneca inks $2bn Treg cell therapy deal with Quell

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which

News

Iovance eyes November FDA decision on melanoma cell therapy

Iovance Biotherapeutics could be a few months away from a first regulatory approval for lifileucel, which could be the first cell-based therapy for a solid tumour in the U

News

ElevateBio cooks up $401m round, garnished with a Novo deal

Cell and gene therapy specialist ElevateBio has taken the total fundraising since it launched five years ago to around $1.25 billion, with its latest $401 million round th

News

Novo Nordisk, Aspect sign $2.6bn diabetes cell therapy deal

Novo Nordisk has put $75 million down on the table to partner Canadian biotech Aspect Biosystems’ cell-based therapies for diabetes and obesity.

News

Mesoblast lifts off as FDA agrees to review GvHD drug again

Regulator has started a priority review of the cell therapy, with a decision due by 2nd August.

News

Gilead's Kite takes control of CAR-T partner Tmunity

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit.

AstraZeneca inks $2bn Treg cell therapy deal with Quell

Iovance eyes November FDA decision on melanoma cell therapy

ElevateBio cooks up $401m round, garnished with a Novo deal

Novo Nordisk, Aspect sign $2.6bn diabetes cell therapy deal

Mesoblast lifts off as FDA agrees to review GvHD drug again

Gilead's Kite takes control of CAR-T partner Tmunity

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Cell Therapy

Editor's Picks